Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future
Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that is more sensitive and specific towards diagnosing any graft injury or rejection. Due to its applicability over all transplanted organs irrespective of age, sex, race, ethnicity, and the non-requirement of a donor sample, it emer...
Main Authors: | Naveen Kumar, Rashmi Rana, Devender Singh Rana, Anurag Gupta, Mohinder Pal Sachdeva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Transplantology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3943/2/3/34 |
Similar Items
-
Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population
by: Naveen Kumar, et al.
Published: (2023-11-01) -
Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01) -
Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem
by: Eleni Avramidou, et al.
Published: (2023-02-01) -
Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
by: Evangelos Mantios, et al.
Published: (2023-10-01) -
Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation
by: Noelia García-Fernández, et al.
Published: (2022-12-01)